Sector
PharmaceuticalsOpen
₹483.95Prev. Close
₹470.7Turnover(Lac.)
₹115.91Day's High
₹483.95Day's Low
₹440.0552 Week's High
₹51552 Week's Low
₹250Book Value
₹20.87Face Value
₹10Mkt Cap (₹ Cr.)
532.44P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 12.03 | 10.56 | 10.56 | 10.56 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 30.34 | 3.98 | 0.72 | -0.51 |
Net Worth | 42.37 | 14.54 | 11.28 | 10.05 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 43.2 | 53.68 | 43.76 | 39.61 |
yoy growth (%) | -19.52 | 22.65 | 10.47 | 21.88 |
Raw materials | -14.57 | -13.61 | -9.55 | -9.19 |
As % of sales | 33.72 | 25.36 | 21.83 | 23.2 |
Employee costs | -13.06 | -16.02 | -12.82 | -11.33 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -6.57 | 1.21 | 3.4 | 3.23 |
Depreciation | -0.81 | -0.67 | -0.5 | -0.56 |
Tax paid | 1.62 | -0.33 | -1.1 | -1.02 |
Working capital | 0.44 | -18.69 | 19.58 | 4.58 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.52 | 22.65 | 10.47 | 21.88 |
Op profit growth | -96.11 | -43.12 | 11.78 | 20.74 |
EBIT growth | -121.69 | -50.88 | 17.13 | 21.95 |
Net profit growth | -664.56 | -61.88 | 4.42 | 27.63 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 125.59 | 108.26 | 93.41 | 80.35 | 62.07 |
Excise Duty | 5.26 | 5.1 | 4.17 | 4.08 | 3.1 |
Net Sales | 120.33 | 103.15 | 89.24 | 76.27 | 58.97 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.82 | 0.3 | 3.12 | 1.14 | 0.11 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.65 | 92.31 | 3,95,326.43 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,537.95 | 78.57 | 1,73,562.03 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,498.35 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,312.75 | 20.48 | 1,09,550.72 | 1,200.7 | 0.61 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,226.65 | 57.31 | 1,09,199.59 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Ramesh Vangal
Non Executive Director
Anand Subramanian
Independent Director
Shilpa Kiran Gududur
Independent Director
Rajesh Sharma
Company Sec. & Compli. Officer
Jyothi Gulecha
Independent Director
SAMIR DHAWAN
Independent Director
Kshiti Ranjan Das
Non Executive Director
Jayarajan Kodikannath
Whole Time Director
K Anilkumar
Independent Director
Harish Menon
VII/415 Nedumbassery,
Athani P O Aluva,
Kerala - 683585
Tel: 91-484-2476301/2/3/4
Website: http://www.keralaavurveda.biz
Email: investor@keralaayurveda.biz; info@keralaayurveda.b
Kences Tower,
2nd Floor No 1, Ramakrishna Street,
Chennai - 600 017
Tel: 91-044-28140801/803
Website: www.integratedindia.in
Email: sureshbabu@iepindia.com/yesbalu@iepindia.com
Summary
Kerala Ayurveda Ltd was established on 6th July 1992. The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Servi...
Read More
Reports by Kerala Ayurveda Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.